4/A//SEC Filing
Cho Man 4/A
Accession 0001209191-20-044365
CIK 0001260990other
Filed
Jul 30, 8:00 PM ET
Accepted
Jul 31, 9:05 PM ET
Size
6.0 KB
Accession
0001209191-20-044365
Insider Transaction Report
Form 4/AAmended
Cho Man
Director
Transactions
- Award
Stock Option
2019-12-18+30,000→ 30,000 totalExercise: $4.11Exp: 2029-12-18→ Common Stock (30,000 underlying)
Footnotes (2)
- [F1]The original Form 4 reported the acquisition of the Stock Options in the "D" column of Column 5. This amendment is being filed to correctly report the acquisition of the Stock Options in the "A" column of Column 5.
- [F2]One thirty-sixth of each Effective Date Award and each Initial Award shall vest and become exercisable in substantially equal installments on each monthly anniversary of the date of grant, so that the options subject to each such type of award shall be fully vested on the three-year anniversary of the date of grant, subject to the Reporting Persons continued service on the Board through each such vesting date.
Documents
Issuer
Oncternal Therapeutics, Inc.
CIK 0001260990
Entity typeother
Related Parties
1- filerCIK 0001797605
Filing Metadata
- Form type
- 4/A
- Filed
- Jul 30, 8:00 PM ET
- Accepted
- Jul 31, 9:05 PM ET
- Size
- 6.0 KB